InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
-24.4%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Wallace Peggy, 董事. Director active across 1 company, notably Cognition Therapeutics INC. Aggregated, 7 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €46k. Activity tracked since 13 October 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wallace Peggy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
25,000 股Common StockSEC:0001104659-26-076472:0
34,000 股0Common StockSEC:0001062993-25-012081:0
8,500 股0Common StockSEC:0001062993-24-012414:0
6,000 股0Common StockSEC:0001062993-23-013440:0
12,500 股@ US$1.2019.0% 占其流量Common StockSEC:0001062993-22-022242:0
标准退出：2023年2月13日 (T+90)
22,461 股0Common StockSEC:0001062993-22-020049:0
3,000 股@ US$12.0068.1% 占其流量Common StockSEC:0001882178-21-000036:0
标准退出：2022年1月11日 (T+90)
7 条申报中的 7 条
About Wallace Peggy
Wallace Peggy is Administrateur at Cognition Therapeutics INC (XNAS). She has 7 filings in total, and among the recent filings available, the transactions are attributed, with EUR 45572 of buys and EUR 0 of sells between 2021-10-25 and 2026-06-22.
